EastPharma Ltd. reported revenue results for the nine months of 2012. For the period, the company reported revenue of USD 170.8 million, down 14.1% from the same period in 2011 of USD 198.8 million. EastPharma's sales decrease was driven by decreased volumes in DEVA's Human Pharma Products businesses.
1st Jan change | Capi. | |
---|---|---|
+21.28% | 44.4B | |
+24.60% | 23.03B | |
+19.22% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B |